Suchergebnisse

Abstract
Purpose
This article investigates survivors' experiences participating in research interviews about technology-facilitated domestic violence. University research ethics committees often assume that participating in research on violence and abuse is distressing for survivors. Scholars have called for research testing this assumption. This article contributes to the evidence base on the benefits and risks of asking research participants about gender-based violence.

Methods
This article is based on semi-structured interviews with 20 Australian domestic violence survivors. Template analysis was used to code the interviews and develop key themes.

Results
The five themes derived from the interviews include reflection on recovery and personal growth; helping other women; rejecting victim-shaming; empowerment; and the importance of timing.

Conclusion
All participants reported positive experiences taking part in the study. However, the authors noticed substantial differences in participant narratives across service cohorts. The implications of recruiting through channels associated with different points in trauma trajectories warrant attention.

Gender‐based violence online is rampant, ranging from harassment of women who are public figures on social media to stalking intimate partners using purpose‐built apps. This is not an issue that can be addressed by individual states alone, nor can it be addressed satisfactorily through legal means. The normalization of misogyny and abuse online both reflects and reinforces systemic inequalities. Addressing gender‐based violence online will require the intervention of the technology companies that govern the commercial Internet to prevent and combat abuse across networks and services. We argue that international human rights instruments provide an opportunity to identify with more precision the responsibilities of telecommunications companies and digital media platforms to mitigate harm perpetrated through their networks, and ensure that the systems they create do not reproduce gendered inequality. Finally, we present initial recommendations for platforms to promote human rights and fulfill their responsibilities under the United Nations Guiding Principles on Business and Human Rights.

Background: Traumatic brain injury is a major cause of death and severe disability worldwide with 1,000,000 hospital admissions per annum throughout the European Union.Therapeutic hypothermia to reduce intracranial hypertension may improve patient outcome but key issues are length of hypothermia treatment and speed of re-warming. A recent meta-analysis showed improved outcome when hypothermia was continued for between 48 hours and 5 days and patients were re-warmed slowly (1°C/4 hours). Previous experience with cooling also appears to be important if complications, which may outweigh the benefits of hypothermia, are to be avoided.Methods/design: This is a pragmatic, multi-centre randomised controlled trial examining the effects of hypothermia 32-35°C, titrated to reduce intracranial pressure 20 mmHg in accordance with the Brain Trauma Foundation Guidelines, 2007.Discussion: The Eurotherm3235Trial is the most important clinical trial in critical care ever conceived by European intensive care medicine, because it was launched and funded by the European Society of Intensive Care Medicine and will be the largest non-commercial randomised controlled trial due to the substantial number of centres required to deliver the target number of patients. It represents a new and fundamental step for ...

BACKGROUND: Traumatic brain injury is a major cause of death and severe disability worldwide with 1,000,000 hospital admissions per annum throughout the European Union.Therapeutic hypothermia to reduce intracranial hypertension may improve patient outcome but key issues are length of hypothermia treatment and speed of re-warming. A recent meta-analysis showed improved outcome when hypothermia was continued for between 48 hours and 5 days and patients were re-warmed slowly (1 °C/4 hours). Previous experience with cooling also appears to be important if complications, which may outweigh the benefits of hypothermia, are to be avoided. METHODS/DESIGN: This is a pragmatic, multi-centre randomised controlled trial examining the effects of hypothermia 32-35 °C, titrated to reduce intracranial pressure 20 mmHg in accordance with the Brain Trauma Foundation Guidelines, 2007. DISCUSSION: The Eurotherm3235Trial is the most important clinical trial in critical care ever conceived by European intensive care medicine, because it was launched and funded by the European Society of Intensive Care Medicine and will be the largest non-commercial randomised controlled trial due to the substantial number of centres required to deliver the target number of patients. It represents a new and fundamental step for intensive care medicine in Europe. Recruitment will continue until January 2013 and interested clinicians from intensive care units worldwide can still join this important collaboration by contacting the Trial Coordinating Team via the trial website http://www.eurotherm3235trial.eu. TRIAL REGISTRATION: Current Controlled Trials ISRCTN34555414.

The key reference guide to rural crime and rural justice, this encyclopedia includes 85 concise and informative entries covering rural crime theories, offences and control. It is divided into five complementary sections: • theories of rural crime; • rural crime studies; • rural criminal justice studies; • rural people and groups; • rural criminological research. With contributions from established and emerging international scholars, this authoritative guide offers state-of-the-art synopses of the key issues in rural crime, criminology, offending and victimisation, and both institutional and informal responses to rural crime